Carboplatin, methotrexate, and vinblastine in the treatment of patients with advanced urothelial cancer. A phase II trial.

Abstract:

BACKGROUND:A Phase II study with carboplatin, methotrexate, and vinblastine (CAMV) was conducted with patients who had advanced urothelial cancer to investigate the activity and toxicity of carboplatin when used in combination chemotherapy. METHODS:Thirty-six patients with advanced urothelial cancer were treated with carboplatin 300 mg/m2 (day 1), methotrexate 40 mg/m2 (days 1 and 8) and vinblastine 4 mg/m2 (days 1 and 8) every 4 weeks. Characteristics of the patients were as follows: men:women, 32:4; median age, 65 years (range, 42-76 years); and median Eastern Cooperative Oncology Group performance status, 0 (range, 0-2). Thirty-six patients were evaluable for toxicity and 33 for response. RESULTS:Objective responses (OR) were achieved in 13 patients: 2 were complete responses (CR) (6%) and 11 were partial responses (33.4%). Median duration of OR was 7 months (range, 3-27 months). Median duration of CR was 10 months (range, 4-27 months), and median survival time for patients achieving complete response was 30.5 months (range, 28-33 months). Patients with a pretreatment creatinine clearance greater than or equal to 50 ml/minute showed a higher response rate: 48% OR and 10% CR. Toxicity was evaluated (World Health Organization criteria) on 164 cycles and was generally mild. CONCLUSION:CAMV is an active and safe regimen in patients with advanced urothelial cancer, even in those with impaired renal function. It is recommended that future studies with this regimen be performed with pharmacokinetic modulation of carboplatin to improve the drug's tolerability and therapeutic activity.

journal_name

Cancer

journal_title

Cancer

authors

Boccardo F,Pace M,Guarneri D,Canobbio L,Curotto A,Martorana G

doi

10.1002/1097-0142(19940401)73:7<1932::aid-cncr2820

subject

Has Abstract

pub_date

1994-04-01 00:00:00

pages

1932-6

issue

7

eissn

0008-543X

issn

1097-0142

journal_volume

73

pub_type

临床试验,杂志文章

相关文献

CANCER文献大全
  • Experimental models for gastric leiomyosarcoma. The effects of N-methyl-N'-nitro-N-nitrosoguanidine in combination with stress, aspirin, or sodium taurocholate.

    abstract::A series of experiments was devised to determine possible modifying effects of stress, aspirin, and sodium taurocholate on the activity of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) in the Buffalo rat stomach. MNNG is a well known, direct-reacting carcinogen, and has been a reliable agent for the experimental product...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19840301)53:5<1088::aid-cncr2820

    authors: Cohen A,Geller SA,Horowitz I,Toth LS,Werther JL

    更新日期:1984-03-01 00:00:00

  • The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with internati

    abstract:BACKGROUND:The authors assessed the prognostic significance of abnormal cyclin dependent kinase inhibitor (CDKI) expression in adenocarcinomas of the uterine cervix. METHODS:Population-based, archival material from patients with International Federation of Gynecology and Obstetrics (FIGO) Stage I and II cervical adeno...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11727

    authors: Alfsen GC,Reed W,Sandstad B,Kristensen GB,Abeler VM

    更新日期:2003-11-01 00:00:00

  • Prostatic intra-epithelial neoplasia and early invasion in prostate cancer.

    abstract::Prostatic intra-epithelial neoplasia (PIN, or intraductal dysplasia) is considered a precursor of invasive carcinoma, characterized by proliferation and anaplasia of cells lining prostatic ducts and acini. The highest grade of PIN, Grade 3, is thought to represent carcinoma in situ. To quantitate the degree of disrupt...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870215)59:4<788::aid-cncr28205

    authors: Bostwick DG,Brawer MK

    更新日期:1987-02-15 00:00:00

  • Modulation of c-Met signaling and cellular sensitivity to radiation: potential implications for therapy.

    abstract::The c-Met/hepatocyte growth factor receptor and its family members are known to promote cancer cell migration and invasion. Signaling within and beyond this pathway contributes to the systemic spread of metastases through induction of the epithelial-mesenchymal transition, a process also implicated in mediating resist...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.27965

    authors: Bhardwaj V,Cascone T,Cortez MA,Amini A,Evans J,Komaki RU,Heymach JV,Welsh JW

    更新日期:2013-05-15 00:00:00

  • Early changes in regenerating hamster pancreas following a single dose of N-nitrosobis (2-oxopropyl)amine (NBOP) administered at the peak of DNA synthesis.

    abstract::A single dose of N-nitrosobis(2-oxopropyl)amine, a carcinogen for hamster pancreas, was administered to hamsters with regenerating pancreas 60 hours after initiation of regeneration when the maximum number of acinar cells are in S phase of the cell cycle. This led to nucleolar segregation and mitotic abnormalities fro...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810315)47:6+<1552::aid-cncr282

    authors: Scarpelli DG,Rao MS

    更新日期:1981-03-15 00:00:00

  • Clinical features of patients who present with metastatic prostate carcinoma and serum prostate-specific antigen (PSA) levels < 10 ng/mL: the "PSA negative" patients.

    abstract:BACKGROUND:Although < 1% of men present with prostate-specific antigen (PSA)-negative prostate carcinoma, in that they have serum PSA levels much lower than the tumor burden would suggest, such patients represent a management dilemma. To the authors' knowledge, little information exists in the literature regarding patt...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11821

    authors: Birtle AJ,Freeman A,Masters JR,Payne HA,Harland SJ,BAUS Section of Oncology Cancer Registry.

    更新日期:2003-12-01 00:00:00

  • Busulfan versus hydroxyurea in long-term therapy of chronic myelogenous leukemia.

    abstract::Survival of patients with chronic myeloid leukemia seen in the University of Colorado Leukemia Clinic were reviewed with respect to therapy. A total of 55 patients seen consecutively through mid 1980 were included in this study. Of these patients 30 were treated with busulfan, 14 were treated with hydroxyurea and 11 r...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19821101)50:9<1683::aid-cncr2820

    authors: Bolin RW,Robinson WA,Sutherland J,Hamman RF

    更新日期:1982-11-01 00:00:00

  • A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment.

    abstract:BACKGROUND:Lenvatinib is an oral, multitargeted tyrosine kinase inhibitor of the vascular endothelial growth factor receptors 1 through 3 (VEGFR1-VEGFR3), fibroblast growth factor receptors 1 through 4 (FGFR1-FGFR4), platelet-derived growth factor receptor α (PDGFRα), ret proto-oncogene (RET), and v-kit Hardy-Zuckerman...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.29395

    authors: Cabanillas ME,Schlumberger M,Jarzab B,Martins RG,Pacini F,Robinson B,McCaffrey JC,Shah MH,Bodenner DL,Topliss D,Andresen C,O'Brien JP,Ren M,Funahashi Y,Allison R,Elisei R,Newbold K,Licitra LF,Sherman SI,Ball DW

    更新日期:2015-08-15 00:00:00

  • Disease control intervals in high-risk neuroblastoma.

    abstract:BACKGROUND:Current salvage therapy for recurrent high-risk neuroblastoma is rarely curative. Assessment of the effectiveness of new, primarily cytostatic agents requires the redefinition of study endpoints to reflect disease stabilization rather than tumor response or regression. The intervals of disease control in the...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23507

    authors: Santana VM,Furman WL,McGregor LM,Billups CA

    更新日期:2008-06-15 00:00:00

  • Immunoblastic sarcoma of B-cells in a 24-month-old child. Report of a case.

    abstract::Immunoblastic sarcoma is a malignancy of transformed lymphocytes with a high association of occurrence in patients with immune disorders. The youngest previously reported case occurred in a 6-year-old child with immunoblastic lymphadenopathy. The authors report the finding of immunoblastic sarcoma of B-cells in a prev...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19841101)54:9<2032::aid-cncr2820

    authors: Larson T,Katz DA,Mailliard JA

    更新日期:1984-11-01 00:00:00

  • The problem of neck relapse in early stage supraglottic larynx cancer.

    abstract::We reviewed the records of 104 patients with Stage T1NO or Stage T2NO epidermoid carcinoma of the supraglottic larynx treated between 1965 and 1979. In 79 patients, surgery was the only type of initial treatment. These 79 patients are the subjects of this report. Forty-eight (61%) of these patients were treated by tot...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19890115)63:2<345::aid-cncr28206

    authors: Levendag P,Sessions R,Vikram B,Strong EW,Shah JP,Spiro R,Gerold F

    更新日期:1989-01-15 00:00:00

  • Hyalinizing clear cell carcinoma: case series and comprehensive review of the literature.

    abstract:BACKGROUND:Hyalinizing clear cell carcinoma (HCCC) is an uncommon malignant salivary gland tumor that was characterized only recently as a distinct entity. Because of its histologic similarity to several other primary and metastatic tumors and its purported favorable clinical outcome after local resection, it is import...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.23974

    authors: Solar AA,Schmidt BL,Jordan RC

    更新日期:2009-01-01 00:00:00

  • A clinical trial of biochemical modulation of 5-fluorouracil with N-phosphonoacetyl-L-aspartate and thymidine in advanced gastric and anaplastic colorectal cancer.

    abstract::A novel sequential administration schedule of PALA (N-phosphonoacetyl-L-aspartate) and thymidine to enhance the cytotoxic effect of 5-fluorouracil (5FU) was tested in 36 patients with advanced gastric cancer and 21 patients with advanced poorly differentiated (anaplastic) colorectal cancer. The potency of 5FU was dram...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19900901)66:5<853::aid-cncr28206

    authors: Windschitl HE,O'Connell MJ,Wieand HS,Krook JE,Rubin J,Moertel CG,Kugler JW,Pfeifle DM,Goldberg RM,Laurie JA

    更新日期:1990-09-01 00:00:00

  • Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy.

    abstract:BACKGROUND:The p53 tumor suppressor gene encodes a nuclear phosphoprotein that is thought to be important to cell cycle regulation and DNA repair and that also may regulate induction of apoptosis by ionizing radiation. Somatic p53 gene mutations occur in 30-50% of breast carcinomas and are associated with poor prognosi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Turner BC,Gumbs AA,Carbone CJ,Carter D,Glazer PM,Haffty BG

    更新日期:2000-03-01 00:00:00

  • A controlled trial of extended radical versus radical mastectomy. Ten-year results.

    abstract::In view of increasing debate over possible benefit of more complete surgery compared to conservative procedures, a randomized controlled trial contrasting the then standard Halsted radical (RDL) operation with the more complete extended radical (EXT) mastectomy was initiated in 1973. Between November 1973 and July 198...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/1097-0142(19890101)63:1<188::aid-cncr28206

    authors: Meier P,Ferguson DJ,Karrison T

    更新日期:1989-01-01 00:00:00

  • Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma.

    abstract:BACKGROUND:Angiogenesis in individuals with various solid tumors has provided useful information on tumor progression and prognosis, and many examples of mast cell (MC) accumulation coupled with angiogenesis can be found in the literature. METHODS:Utilizing monoclonal antibodies for tryptase that are specific markers ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Takanami I,Takeuchi K,Naruke M

    更新日期:2000-06-15 00:00:00

  • Survivorship after lower gastrointestinal cancer: Patient-reported outcomes and planning for care.

    abstract:BACKGROUND:There is significant need for quality follow-up care to optimize long-term outcomes for the growing population of lower gastrointestinal (GI) cancer survivors. Patient-reported outcomes (PROs) provide valuable information regarding late and long-term effects (LLTEs). METHODS:A convenience sample from 1129 c...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.30527

    authors: Frick MA,Vachani CC,Hampshire MK,Bach C,Arnold-Korzeniowski K,Metz JM,Hill-Kayser CE

    更新日期:2017-05-15 00:00:00

  • Chemotherapy as a substitute for surgery in the treatment advanced resectable head and neck cancer. A report from the Northern California Oncology Group.

    abstract::This trial determines the feasibility for patients with resectable Stages III/IV head and neck cancer who achieved a complete response to induction chemotherapy of eliminating surgery from their treatment program. Thirty patients were treated with three cycles of cisplatin and 5-fluorouracil (5-FU), followed by reendo...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19870915)60:6<1178::aid-cncr2820

    authors: Jacobs C,Goffinet DR,Goffinet L,Kohler M,Fee WE

    更新日期:1987-09-15 00:00:00

  • Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis.

    abstract:BACKGROUND:Pigmented villonodular synovitis (PVNS) (also known as diffuse-type giant cell tumor) and tenosynovial giant cell tumors (TGCT) are rare, usually benign neoplasms that affect the synovium and tendon sheaths in young adults. These tumors are driven by the overexpression of colony stimulating factor-1 (CSF1). ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.26409

    authors: Cassier PA,Gelderblom H,Stacchiotti S,Thomas D,Maki RG,Kroep JR,van der Graaf WT,Italiano A,Seddon B,Dômont J,Bompas E,Wagner AJ,Blay JY

    更新日期:2012-03-15 00:00:00

  • Establishment of an Epstein-Barr virus-negative B-cell lymphoma line from a Japanese Burkitt's lymphoma and its serial passage in hamsters.

    abstract::An Epstein-Barr virus (EBV)-negative lymphoma line (JBL) was established in vitro from pleural effusion of an EBV-seropositive 29-year-old Japanese female with Burkitt's lymphoma. JBL cells as well as her original lymphoma cells bore monoclonal surface IgM with lambda light chains. The JBL line grew in single cell sus...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197712)40:6<2999::aid-cncr282040

    authors: Miyoshi I,Hiraki S,Kubonishi I,Matsuda Y,Kishimoto H,Nakayama T,Tanaka T,Masuji H,Kimura I

    更新日期:1977-12-01 00:00:00

  • Tumor vaccine for ovarian carcinoma targeting sperm protein 17.

    abstract:BACKGROUND:The authors previously identified sperm protein 17 (Sp17) as being expressed in patients with multiple myeloma. The restricted expression of Sp17 in normal tissue makes it an ideal target for tumor vaccine. In the current study, the authors extended their research to include ovarian carcinoma. METHODS:A pai...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.10506

    authors: Chiriva-Internati M,Wang Z,Salati E,Timmins P,Lim SH

    更新日期:2002-05-01 00:00:00

  • Correlation between clinical outcome and growth factor pathway expression in osteogenic sarcoma.

    abstract:BACKGROUND:Multiple cell-signaling ligands and receptors-including vascular endothelial growth factor (VEGF), insulin-like growth factor (IGF), endothelial growth factor (EGF), v-akt murine thymoma viral oncogene homolog (AKT), platelet-derived growth factor (PDGF), mitogen-activated protein kinase (MAPK), and 70-kilod...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24562

    authors: Abdeen A,Chou AJ,Healey JH,Khanna C,Osborne TS,Hewitt SM,Kim M,Wang D,Moody K,Gorlick R

    更新日期:2009-11-15 00:00:00

  • Disparities in participation in cancer clinical trials in the United States : a symptom of a healthcare system in crisis.

    abstract::Disparities in minorities' representation in cancer clinical trials have been shown only in adult populations, which suggest that the main causes of these disparities relate to health system-based barriers, including issues of poverty (lack of insurance), poor access to trials, and an inadequate number of clinical tri...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23201

    authors: Colon-Otero G,Smallridge RC,Solberg LA Jr,Keith TD,Woodward TA,Willis FB,Dunn AN

    更新日期:2008-02-01 00:00:00

  • Metastatic patterns at autopsy in patients with ovarian carcinoma.

    abstract:BACKGROUND:Previously published studies concerning autopsy findings in ovarian cancer failed to consider the broad differences in factors that influence the course of disease. Furthermore, those studies were conducted when the currently accepted standards in diagnostics and therapy had not been fully established. The o...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.22919

    authors: Güth U,Huang DJ,Bauer G,Stieger M,Wight E,Singer G

    更新日期:2007-09-15 00:00:00

  • Prophylaxis in ovarian cancer.

    abstract::The only prophylaxis for ovarian cancer is oophorectomy, except in the very rare case when an ovarian cancer appears to arise from the mesothelial tissue of the abdominal cavity. It has been shown that women who have taken the oral contraceptive pill for 4 or 5 years decreases the incidence of ovarian cancer by approx...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.2820710419

    authors: Barber HR

    更新日期:1993-02-15 00:00:00

  • Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis.

    abstract:BACKGROUND:Ovarian surface epithelial cells are positionally organized as a single cell layer by a sheet of basement membrane. It is believed that the contact of the ovarian surface epithelial cells with the basement membrane regulates cell growth and ensures the organization of the epithelium. Disabled-2 (Dab2), a sig...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.10870

    authors: Capo-Chichi CD,Smith ER,Yang DH,Roland IH,Vanderveer L,Cohen C,Hamilton TC,Godwin AK,Xu XX

    更新日期:2002-10-15 00:00:00

  • Beta-glucuronidase activity in prostatic carcinoma and benign prostatic hyperplasia.

    abstract::Beta-glucuronidase activity was extracted from prostatic carcinomas and hyperplastic prostates. It was 3.6-fold higher (P less than 0.0001) in prostatic carcinoma than in prostatic hyperplasia. Analysis for isoenzymes of prostatic beta-glucuronidase by disc-gel electrophoresis in nondenaturing polyacrylamide gels demo...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19890815)64:4<911::aid-cncr28206

    authors: Pearson JP,Pretlow TP,Bradley EL Jr,McGinnis MC,Pretlow TG

    更新日期:1989-08-15 00:00:00

  • Differences in the angiogenesis of benign and malignant ovarian tumors, demonstrated by analyses of color Doppler ultrasound, immunohistochemistry, and microvessel density.

    abstract:BACKGROUND:To clarify the differences in angiogenesis between benign and malignant ovarian tumors, the authors examined the immunohistochemical characteristics and the density of tumor vessels in both tumor groups. Intratumoral vascularization was observed preoperatively by transvaginal color Doppler ultrasound. METHO...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Emoto M,Iwasaki H,Mimura K,Kawarabayashi T,Kikuchi M

    更新日期:1997-09-01 00:00:00

  • Clinical experience with leucovorin and 5-fluorouracil.

    abstract::Two trials of leucovorin (LV) and 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer were done, both using a 3-day loading dose and then weekly doses to minimize toxicity. The first trial used LV administered by intravenous infusion with a constant dose of 5-FU 400 mg/m2, and the second trail used ora...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19890315)63:6+<1031::aid-cncr282

    authors: Laufman LR,Brenckman WD Jr,Stydnicki KA,Morgan ED,Collier M,Knick VB,Duch DS,Mullin R,Ferone R

    更新日期:1989-03-15 00:00:00

  • Phase 1 study of an oxaliplatin and etoposide regimen in pediatric patients with recurrent solid tumors.

    abstract:BACKGROUND:The combination of a platinating agent and etoposide has induced responses in various pediatric tumors. The study estimated the maximum tolerated dose (MTD) of an oxaliplatin and etoposide regimen in children with recurrent solid tumors. METHODS:Oxaliplatin was administered on Day 1 and etoposide on Days 1 ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24054

    authors: McGregor LM,Spunt SL,Santana VM,Stewart CF,Ward DA,Watkins A,Laningham FH,Ivy P,Furman WL,Fouladi M

    更新日期:2009-02-01 00:00:00